The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference

Rhea-AI Summary

The Oncology Institute (NASDAQ: TOI) announced that Chief Medical Officer Yale D. Podnos, MD, MPH, FACS, will speak at the APG Spring Conference on May 28, 2026, in San Diego.

He will join a panel on Engaging More Specialists in Value-Based Care, sharing oncology-focused insights on outcomes, costs, care quality, and patient safety.

News Market Reaction – TOIIW

+11.32%

+11.32% Session close to close

In the May 26 session, TOIIW gained 11.32%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +11.3% in the session following this news. A strong positive reaction aligns with r...

Analysis

The stock surged +11.3% in the session following this news. A strong positive reaction aligns with recent patterns where operational updates and visibility events coincided with sizable moves, such as prior gains of 19.76%, 33.33%, and 55.97% on earlier news. However, the current announcement centers on a conference panel rather than new financial or clinical data, which can make follow-through less certain compared with earnings or measurable savings updates.

Key Figures

Conference date: May 28, 2026

1 metrics

Conference date May 28, 2026 APG Spring Conference panel participation

Historical Context

5 past events · Latest: May 13 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 13	Investor conference	Positive	+19.8%	Management participation in B. Riley institutional investor conference and webcast access.
May 07	Earnings release	Positive	+33.3%	Q1 2026 results with strong revenue growth and narrowed net loss.
Apr 27	Earnings date set	Neutral	-0.4%	Announcement of Q1 2026 earnings release date and conference call details.
Apr 13	Medicare savings	Positive	+56.0%	Reported $1.8 million Medicare savings and maximum quality scores in CMS model.
Apr 09	Healthcare conference	Positive	-1.9%	Participation in 25th Annual Needham Healthcare Conference with webcast presentation.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive operational or visibility news has often aligned with strong positive moves in recent months.

Recent Company History

Over the past few months, The Oncology Institute has combined operational progress with growing investor engagement. In April 2026, it reported $1.8 million in Medicare savings with strong quality scores, followed by a Q1 2026 report showing revenue of $147.4 million, up 41.2% year-over-year. Conference participation, including the Needham and B. Riley events, has been frequent. These prior news items often coincided with sizable positive price reactions, framing the latest conference-focused announcement within an ongoing visibility and growth narrative.

Key Terms

value-based care

1 terms

value-based care medical

"The session, "Engaging More Specialists in Value-Based Care," will bring together..."

A health-care delivery approach that rewards providers for keeping patients healthy and improving outcomes instead of charging for each test or visit. For investors, it matters because it shifts where profits and losses come from—favoring providers and technologies that lower long-term costs, prevent complications, and demonstrate measurable results; think of it like paying a contractor only when the house stays sound, which changes who wins and loses financially.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CERRITOS, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Yale D. Podnos, MD, MPH, FACS, Chief Medical Officer, will participate in a panel discussion at the APG Spring Conference on May 28, 2026, in San Diego. The session, "Engaging More Specialists in Value-Based Care," will bring together healthcare leaders to discuss the growing role of specialists in advancing value-based care.

"Specialists play a critical role in delivering high-quality, coordinated care while helping improve outcomes and reduce the total cost of care," said Dr. Podnos. "As oncology continues to evolve, value-based models create opportunities to enhance the patient experience, maximize quality of life and survival outcomes, and improve care quality and patient safety."

Dr. Podnos will share insights on oncology's role in improving outcomes, reducing costs, and advancing value-based care delivery.

About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors
ICR Healthcare
TOI@icrhealthcare.com

FAQ

What did The Oncology Institute (NASDAQ: TOI) announce on May 26, 2026?

The Oncology Institute announced that its Chief Medical Officer, Dr. Yale D. Podnos, will speak on a value-based care panel at the APG Spring Conference. According to The Oncology Institute, he will address oncology’s role in outcomes, costs, and care quality.

When and where will The Oncology Institute’s CMO speak at the APG Spring Conference 2026?

Dr. Yale D. Podnos will participate in a panel discussion on May 28, 2026, in San Diego at the APG Spring Conference. According to The Oncology Institute, the session focuses on engaging specialists in value-based care models.

What is the topic of The Oncology Institute CMO’s panel at the APG Spring Conference?

The panel is titled “Engaging More Specialists in Value-Based Care” and will explore specialists’ roles in advancing value-based models. According to The Oncology Institute, Dr. Podnos will emphasize oncology’s contribution to improving outcomes, reducing costs, and enhancing patient experience.

How does The Oncology Institute describe specialists’ role in value-based care?

According to The Oncology Institute, specialists are critical for delivering high-quality, coordinated care while helping improve outcomes and reduce total cost of care. Dr. Podnos highlights how oncology within value-based models can enhance patient experience, quality of life, survival, and safety.

What insights will The Oncology Institute’s CMO share about oncology and value-based care?

Dr. Podnos will share insights on oncology’s role in improving clinical outcomes, reducing overall healthcare costs, and advancing value-based care delivery. According to The Oncology Institute, he will focus on patient experience, quality of life, survival outcomes, care quality, and patient safety.